Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer

603.0500 -0.65 (-0.11%)

NSE May 16, 2025 15:31 PM

56.45% Gain from 52W Low

Volume: 1.5M

Laurus Labs Ltd.

29 Apr 2022

603.05

-0.11%

Laurus Labs (HOLD): Mixed Q4; non-ARV business guided to drive $1bn in sales

Hold: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Q4 topline growth 14% ahead of consensus as healthy CDMO, FDF and non-ARV API sales offset decline in ARV business

Laurus Labs Ltd. is trading below its 30 day SMA of 609.8